Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

During the Trading Day
6.41 -0.06 / -0.93%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.41 -0.0018 / -0.03%
Volume: 47.2K
Health Technology

Company Description

ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Its products includes Iclusig (ponatinib), Brigatinib (previously known as AP26113), and AP32788. The company was founded by Harvey J. Berger in April 1991 and is headquartered in Cambridge, MA.

Contact Information

ARIAD Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge Massachusetts 02139-4234
P:(617) 494-0400
Investor Relations:
(617) 503-7028



Mutual fund holders37.48%
Other institutional35.70%
Individual stakeholders10.59%

Top Executives

Harvey J. BergerChairman, President & Chief Executive Officer
Edward M. FitzgeraldChief Financial Officer, Treasurer & Executive VP
Timothy P. ClacksonChief Scientific Officer
Frank G. HaluskaChief Medical Officer
Nicholas VentrescaChief Information Officer & Senior Vice President